Provided by Tiger Trade Technology Pte. Ltd.

NEXGEL, INC.

0.3300
-0.0573-14.79%
Post-market: 0.33800.0080+2.42%19:59 EDT
Volume:350.66K
Turnover:122.15K
Market Cap:3.22M
PE:-0.44
High:0.3700
Open:0.3700
Low:0.3292
Close:0.3873
52wk High:2.89
52wk Low:0.3003
Shares:9.75M
Float Shares:7.69M
Volume Ratio:0.41
T/O Rate:4.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7502
EPS(LYR):-0.3820
ROE:-115.07%
ROA:-18.67%
PB:0.65
PE(LYR):-0.86

Loading ...

NexGel gets Nasdaq notice for failing $1 minimum bid price rule

Reuters
·
Apr 25

BRIEF-Nexgel Inc Co And Celularity Enter Amendment No. 1 To License Agreement On April 17, 2026

Reuters
·
Apr 22

Nexgel Inc - Co and Celularity Enter Amendment No. 1 to License Agreement on April 17, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 22

Nexgel Inc - Co to Pay Celularity $13.3 Mln Including $8.3 Mln Cash and $5 Mln Convertible Note - SEC Filing

THOMSON REUTERS
·
Apr 22

Nexgel partners with Sequence LifeScience in $5.5 million financing for Celularity deal

Reuters
·
Apr 21

Celularity closes biomaterials asset sale and license deal with NexGel for $13.3 million

Reuters
·
Apr 21

NexGel Q4 EPS $(0.12) Misses $(0.09) Estimate, Sales $2.796M Miss $3.240M Estimate

Benzinga Earnings
·
Apr 01

Nexgel Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Mar 28

Nexgel updates its financial calendar; management hosts a conference call at 4:30 P.M. ET

Reuters
·
Mar 25

Nexgel Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Mar 21

NexGel price target lowered to $2 from $6 at Maxim

TIPRANKS
·
Mar 12

Nexgel Inc - Consideration Includes $15 Mln Upfront Cash and up to $20 Mln in Milestone Payments

THOMSON REUTERS
·
Mar 12

Nexgel Inc - Deal Expected to Triple Annual Revenue to $35 Mln and Make Company Profitable Upon Closing

THOMSON REUTERS
·
Mar 12

Celularity reiterates strategic commercialization partnership with NEXGEL

TIPRANKS
·
Mar 12

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

GlobeNewswire
·
Mar 12

NexGel sign agreement to license, acquire portfolio of products from Celularity

TIPRANKS
·
Mar 10

Nexgel Inc - Expects to Close $14.9 Mln in Additional Financing in Q1 or Early Q2 2026

THOMSON REUTERS
·
Mar 10

Nexgel Inc - Deal Expected to Triple Annual Revenue to $35 Mln and Make Nexgel Profitable

THOMSON REUTERS
·
Mar 10